SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001390478-13-000033
Filing Date
2013-11-07
Accepted
2013-11-06 19:10:14
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A gale-20130930x10qa.htm 10-Q/A 987563
2 EX-31.1 gale-20130930xex311.htm EX-31.1 8180
3 EX-31.2 gale-20130930xex312.htm EX-31.2 8282
4 EX-32.1 gale-20130930xex321.htm EX-32.1 6976
  Complete submission text file 0001390478-13-000033.txt   7228702

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT gale-20130930.xml EX-101.INS 1027767
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gale-20130930.xsd EX-101.SCH 56138
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gale-20130930_cal.xml EX-101.CAL 75214
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gale-20130930_def.xml EX-101.DEF 175043
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gale-20130930_lab.xml EX-101.LAB 639711
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gale-20130930_pre.xml EX-101.PRE 347427
Mailing Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034
Business Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-33958 | Film No.: 131197915
SIC: 2834 Pharmaceutical Preparations